FDA 483 - Barr Laboratories Inc.

Barr Laboratories, Inc. in Forest, VA, was inspected from February 21-28, 2018, and received one observation. The inspection revealed inadequate qualification of the lyophilization process for Adenovirus Type 4 and 7, which was a repeat observation from a previous inspection. This indicates a persistent issue with production and process controls.